LONDON, May 24, 2018 /PRNewswire/ --
Baptist Gallwitz; European Endocrinology. 2018;14(1):17-23DOI: https://doi.org/10.17925/EE.2018.14.1.17
(Logo: http://mma.prnewswire.com/media/515766/Touch_Medical_Logo.jpg )
Published recently in European Endocrinology, the peer-reviewed, PubMed-indexed journal from touchENDOCRINOLOGY,
The full peer-reviewed, open-access article is available here:
Disclosure: Baptist Gallwitz discloses the following: Board Member/Advisory Panel for Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Janssen, Merck Sharp & Dohme, Mylan, Novartis, Novo Nordisk. Speaker honoraria: Amgen, Abbott, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly & Co., Merck Sharp & Dohme, Novo Nordisk, Sanofi. The publication of this article was supported by AstraZeneca. The views and opinions expressed are those of the author and do not necessarily reflect those of AstraZeneca.
touchENDOCRINOLOGY (a division of Touch Medical Media) publishesEuropean Endocrinology, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of endocrinology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
Touch Medical Media is a trading name of Touch Digital Media Limited, a private limited company registered in England and Wales at The White House Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142.
For inquires please contact: Nicola Cartridge - Editorial Director firstname.lastname@example.org +44-(0)-207-193-3186
Leading the Debate on the Advances in Healthcare
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All